Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction
Authors
Keywords
-
Journal
Circulation-Heart Failure
Volume 12, Issue 7, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-06-21
DOI
10.1161/circheartfailure.119.006125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial
- (2019) Orly Vardeny et al. EUROPEAN JOURNAL OF HEART FAILURE
- The Role of the Clinical Examination in Patients With Heart Failure
- (2018) Jennifer T. Thibodeau et al. JACC-Heart Failure
- Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction
- (2018) Peder Langeland Myhre et al. JAMA Cardiology
- The effects of short-term omission of daily medication on the pathophysiology of heart failure
- (2017) Silviu Dovancescu et al. EUROPEAN JOURNAL OF HEART FAILURE
- Non-invasive measurement of right atrial pressure by near-infrared spectroscopy: preliminary experience. A report from the SICA-HF study
- (2017) Pierpaolo Pellicori et al. EUROPEAN JOURNAL OF HEART FAILURE
- Systolic blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: an analysis of the TOPCAT trial
- (2017) Senthil Selvaraj et al. EUROPEAN JOURNAL OF HEART FAILURE
- Efficacy and Safety of Spironolactone in Acute Heart Failure
- (2017) Javed Butler et al. JAMA Cardiology
- Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure
- (2016) Pierpaolo Pellicori et al. CARDIOVASCULAR DRUGS AND THERAPY
- Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction
- (2016) Sanjiv J. Shah et al. CIRCULATION
- Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialCLINICAL PERSPECTIVE
- (2016) Eldrin F. Lewis et al. Circulation-Heart Failure
- To truly look inside
- (2016) Paddy M Barrett et al. LANCET
- Alteration of amiloride-sensitive salt taste nerve responses in aldosterone/NaCl-induced hypertensive rats
- (2016) Takashi Sakamoto et al. NEUROSCIENCE RESEARCH
- How valuable is physical examination of the cardiovascular system?
- (2016) Andrew Elder et al. BMJ-British Medical Journal
- How valuable is physical examination of the cardiovascular system?
- (2016) Andrew Elder et al. BMJ-British Medical Journal
- Utility of Patient-Reported Outcome Instruments in Heart Failure
- (2016) Anita A. Kelkar et al. JACC-Heart Failure
- The Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure with Preserved Ejection Fraction and the Impact of Spironolactone
- (2015) Amil M. Shah et al. Circulation-Heart Failure
- Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart FailureCLINICAL PERSPECTIVE
- (2015) Anuradha Lala et al. Circulation-Heart Failure
- Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction
- (2014) Philip B. Adamson et al. Circulation-Heart Failure
- Effects of Spironolactone Treatment in Elderly Women With Heart Failure and Preserved Left Ventricular Ejection Fraction
- (2014) Karla M. Kurrelmeyer et al. JOURNAL OF CARDIAC FAILURE
- Prognostic Value of the Physical Examination in Patients With Heart Failure and Atrial Fibrillation
- (2014) Guillem Caldentey et al. JACC-Heart Failure
- Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial
- (2013) A. P. Ambrosy et al. EUROPEAN HEART JOURNAL
- Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
- (2013) Frank Edelmann et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence, Clinical Phenotype, and Outcomes Associated With Normal B-Type Natriuretic Peptide Levels in Heart Failure With Preserved Ejection Fraction
- (2012) Venkatesh Y. Anjan et al. AMERICAN JOURNAL OF CARDIOLOGY
- Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction
- (2011) Akshay S. Desai et al. AMERICAN HEART JOURNAL
- Bedside Assessment of Cardiac Hemodynamics: The Impact of Noninvasive Testing and Examiner Experience
- (2011) Aaron M. From et al. AMERICAN JOURNAL OF MEDICINE
- Does the physical examination still have a role in patients with suspected heart failure?
- (2011) Thibaud Damy et al. EUROPEAN JOURNAL OF HEART FAILURE
- Results of the Randomized Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction Trial (RAAM-PEF)
- (2011) Anita Deswal et al. JOURNAL OF CARDIAC FAILURE
- The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction
- (2009) Miloš Kubánek et al. EUROPEAN JOURNAL OF HEART FAILURE
- Value of Clinician Assessment of Hemodynamics in Advanced Heart Failure
- (2008) Mark H. Drazner et al. Circulation-Heart Failure
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now